| Dir : /home/ithome/mail/new/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/new/1773931115.M207461P23263.host100322.itwesthosting.com,S=15511,W=15855 |
Return-Path: <allen@manusubmit.com>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id rngwDGsKvGnfWgAAp0YrwQ
(envelope-from <allen@manusubmit.com>)
for <ithome@host100322.itwesthosting.com>; Thu, 19 Mar 2026 15:38:35 +0100
Return-path: <allen@manusubmit.com>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Thu, 19 Mar 2026 15:38:35 +0100
Received: from postal6.manusubmit.com ([15.235.91.237]:58225 helo=postal10.manusubmit.com)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <allen@manusubmit.com>)
id 1w3EW9-000634-26
for senka.rendulic@bolnica-lipik.hr;
Thu, 19 Mar 2026 15:38:35 +0100
DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/relaxed;
d=manusubmit.com; s=mail; h=Content-Type:MIME-Version:Message-ID:Date:Subject
:To:From:Sender:Reply-To:Cc:Content-Transfer-Encoding:Content-ID:
Content-Description:Resent-Date:Resent-From:Resent-Sender:Resent-To:Resent-Cc
:Resent-Message-ID:In-Reply-To:References:List-Id:List-Help:List-Unsubscribe:
List-Subscribe:List-Post:List-Owner:List-Archive;
bh=8ZNd8sIYDWyERWfZSDxy/iThSbwMjavtgSZJMM08iLU=; b=NOVa8FizY5cMa12riNat4/VaBm
ONB2Vt4Mn7KcPnG11hvuNLGpVP7dAEKnn7JfFO7f68x66nB88S9Ij8s6TWpX5aeJBheIZhm91zzR0
g+y23hPiei9BqkSbx/aCIdtI+nV4DfDUsq7jTGkfH1KazhTTAUW9Ds36O8uI8NhqDfpg=;
Received: from [205.254.169.140] (helo=DESKTOPGJ5R03M)
by postal.manusubmit.com with esmtpa (Exim 4.96)
(envelope-from <allen@manusubmit.com>)
id 1w3DJ5-007Jkk-02
for senka.rendulic@bolnica-lipik.hr;
Thu, 19 Mar 2026 13:20:59 +0000
From: <allen@manusubmit.com>
To: <senka.rendulic@bolnica-lipik.hr>
Subject: senka.rendulic@bolnica-lipik.hr|Disease Activity, Inflammation Markers, and Quality of Life Are Associated with Muscle Strength in Croatian Rheumatoid Arthritis Patients?A National-Based Study
Date: Thu, 19 Mar 2026 18:50:34 +0530
Message-ID: <5b98201dcb7a3$39cab350$ad6019f0$@manusubmit.com>
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_NextPart_000_5B983_01DCB7D1.538475F0"
Thread-Index: Ady3oyn9833Gsq7FQ2+dCK3KqbbiIQ==
Content-Language: en-in
X-Spam-Status: No, score=4.3
X-Spam-Score: 43
X-Spam-Bar: ++++
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Regards, Senka Renduli? Slivar Since you didn't reply to our
letter on the date below, we're writing to you again in the hopes that you
will give our request some thought this time. If you reply to our message,
we can identify the issue and attempt to solve it.
Content analysis details: (4.3 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: doi.org]
4.5 URIBL_DBL_SPAM Contains a spam URL listed in the Spamhaus DBL
blocklist
[URIs: manusubmit.com]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[15.235.91.237 listed in bl.score.senderscore.com]
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[15.235.91.237 listed in sa-accredit.habeas.com]
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
0.0 KAM_SHORT Use of a URL Shortener for very short URL
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
This is a multipart message in MIME format.
------=_NextPart_000_5B983_01DCB7D1.538475F0
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Regards, Senka Renduli? Slivar
Since you didn't reply to our letter on the date below, we're writing to =
you
again in the hopes that you will give our request some thought this =
time.
If you reply to our message, we can identify the issue and attempt to =
solve
it.
Kindly use this email address to send a paper and a cover letter. Kindly
notify us within a day if you accept.
Link to the reliable OJS-Submission System:
https://dx.doi.org/10.17352/ojpdt
When the next issue arises, I hope you can assist us.
In order to stop the follow-ups, kindly respond.
Sincerely,
Rebecca Thornton, Journal Communication Associate=20
<https://postal.manusubmit.com/> Open Journal of Parkinson's Disease =
and
Treatment (ISSN: 2692-4617)
______________________________________________
Sent: December 10, 2025, Monday, 9:00:16 AM
To: senka.rendulic@bolnica-lipik.hr =
<mailto:senka.rendulic@bolnica-lipik.hr>
Subject: OJPDT|senka.rendulic@bolnica-lipik.hr
<mailto:senka.rendulic@bolnica-lipik.hr>=20
Regards, Senka Renduli? Slivar
This is a polite reminder about what we discussed earlier.
We're writing to inquire further about the anticipated submission of =
your
manuscript. The March Issue content is currently being finalized by the
journal, and we would be happy to consider your excellent contribution =
for
this edition.
We respectfully ask that you send in your manuscript and cover letter by =
the
end of this month if it is prepared for review and publication. =
Submissions
will be taken into consideration for the next issue if they are received
within this time frame.
Crucial details:
The submission status is open and accepting manuscripts at this time.
Anticipated release: April volume and issue
Confirmation deadline: April 03, 2026
We respectfully ask for your confirmation by responding with one of the
following choices so that we can effectively resolve the matter:
Yes, this month I will submit the manuscript.
Please let us know if more time is needed by the deadline. To fulfill
publication deadlines, we will move forward with alternate submissions =
if we
don't hear back.
Your time is greatly appreciated, and we truly value your affiliation =
with
the journal. We're eager to hear from you.
Greetings,
Rebecca Thornton, Journal Communication Associate
Open Journal of Parkinson's Disease and Treatment (ISSN: 2692-4617)
|EIDT1052-OJPDT|
This email is part of our scholarly engagement with researchers whose =
work
appears in publicly available academic platforms.
If you prefer not to receive further communications, please reply with
=93Unsubscribe=94.
=20
------=_NextPart_000_5B983_01DCB7D1.538475F0
Content-Type: text/html;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head><meta name=3DGenerator =
content=3D"Microsoft Word 15 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:0cm;
line-height:106%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]--></head><body lang=3DEN-IN =
link=3D"#0563C1" vlink=3D"#954F72"><div class=3DWordSection1><p =
class=3DMsoNormal =
style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-height:normal'><b><=
span style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'>Regards, Senka Renduli? =
Slivar</span></b><span style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'><br><br>Since you didn't reply =
to our letter on the date below, we're writing to you again in the hopes =
that you will give our request some thought this time.<br><br>If you =
reply to our message, we can identify the issue and attempt to solve =
it.<br><br>Kindly use this email address to send a paper and a cover =
letter. Kindly notify us within a day if you =
accept.<o:p></o:p></span></p><p class=3DMsoNormal =
style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-height:normal'><spa=
n style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'><br><b>Link to the reliable =
OJS-Submission System: <span style=3D'color:#0070C0'><a =
href=3D"https://dx.doi.org/10.17352/ojpdt">https://dx.doi.org/10.17352/oj=
pdt</a></span></b><span style=3D'color:#0070C0'><br></span>When the next =
issue arises, I hope you can assist us.<br><br>In order to stop the =
follow-ups, kindly respond.<br><br>Sincerely,<o:p></o:p></span></p><p =
class=3DMsoNormal =
style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-height:normal'><spa=
n style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'>Rebecca Thornton, Journal =
Communication Associate <o:p></o:p></span></p><p class=3DMsoNormal =
style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-height:normal'><spa=
n style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;color:#7030A0;mso-fareast-language:EN-IN'> <span =
class=3DMsoHyperlink><b><span style=3D'color:#7030A0'><a =
href=3D"https://postal.manusubmit.com/"><span =
style=3D'color:#7030A0'>Open Journal of Parkinson's Disease and =
Treatment (ISSN: 2692-4617)</span></a></span></b></span></span><span =
style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'><br></span><span =
style=3D'color:black'>______________________________________________</spa=
n><span style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'><o:p></o:p></span></p><p =
class=3DMsoNormal =
style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-height:normal'><spa=
n style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'><br>Sent: December 10, 2025, =
Monday, 9:00:16 AM<br>To: <a =
href=3D"mailto:senka.rendulic@bolnica-lipik.hr">senka.rendulic@bolnica-li=
pik.hr</a><br>Subject: OJPDT|<a =
href=3D"mailto:senka.rendulic@bolnica-lipik.hr">senka.rendulic@bolnica-li=
pik.hr</a><br><br><b>Regards, Senka Renduli? Slivar<br></b><br>This is a =
polite reminder about what we discussed earlier.<br><br>We're writing to =
inquire further about the anticipated submission of your manuscript. The =
<b>March </b>Issue content is currently being finalized by the journal, =
and we would be happy to consider your excellent contribution for this =
edition.<br><br>We respectfully ask that you send in your manuscript and =
cover letter by the end of this month if it is prepared for review and =
publication. Submissions will be taken into consideration for the next =
issue if they are received within this time frame.<br><br><b><span =
style=3D'color:#538135'>Crucial details:</span></b><br><br>The =
submission status is open and accepting manuscripts at this =
time.<br><br>Anticipated release: April volume and =
issue<br><br>Confirmation deadline: April 03, 2026<br><br><b><span =
style=3D'color:#0D0D0D'>We respectfully ask for your confirmation by =
responding with one of the following choices so that we can effectively =
resolve the matter:<br></span></b><br><b><span =
style=3D'color:#00B050;background:yellow;mso-highlight:yellow'>Yes, this =
month I will submit the manuscript.</span><span =
style=3D'color:#00B050'><br></span></b><br>Please let us know if more =
time is needed by the deadline. To fulfill publication deadlines, we =
will move forward with alternate submissions if we don't hear =
back.<br><br>Your time is greatly appreciated, and we truly value your =
affiliation with the journal. We're eager to hear from =
you.<br><br>Greetings,<o:p></o:p></span></p><p class=3DMsoNormal =
style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-height:normal'><spa=
n style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'>Rebecca Thornton, Journal =
Communication Associate<o:p></o:p></span></p><p class=3DMsoNormal =
style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-height:normal'><spa=
n style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'> <b><span =
style=3D'color:#7030A0'>Open Journal of Parkinson's Disease and =
Treatment (ISSN: 2692-4617)</span><o:p></o:p></b></span></p><p =
class=3DMsoNormal =
style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-height:normal'><spa=
n style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;color:#A6A6A6;mso-fareast-language:EN-IN'>|EIDT1052-OJPDT|</=
span><span style=3D'font-size:12.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'><br><br><br></span><span =
style=3D'font-size:10.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'>This email is part of our =
scholarly engagement with researchers whose work appears in publicly =
available academic platforms.<o:p></o:p></span></p><p class=3DMsoNormal =
style=3D'margin-bottom:0cm;margin-bottom:.0001pt;line-height:normal'><spa=
n style=3D'font-size:10.0pt;font-family:"Times New =
Roman",serif;mso-fareast-language:EN-IN'>If you prefer not to receive =
further communications, please reply with =
“Unsubscribe”.<o:p></o:p></span></p><p =
class=3DMsoNormal><o:p> </o:p></p></div></body></html>
------=_NextPart_000_5B983_01DCB7D1.538475F0--